Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Feb 05 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-05-2021-1

Cadila Healthcare Limited has informed the Exchange regarding a press release dated February 05, 2021, titled "Zydus completes large scale enrolment for two Phase III trials of Desidustat".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases